NHS prescribing requires a separate NICE technology appraisal
Industry trackers have estimated a possible NDA submission in late 2026 or early 2027 based on the pace of Phase 3 readouts, with potential approval roughly ten months after submission under standard review but Eli Lilly has not published an official timeline, and it depends on the outcome of the remaining TRIUMPH trials
By activating GLP-1 receptors, these diabetes medications not only improve glucose metabolism but also promote feelings of fullness, making them effective for weight loss
Healthcare professionals should adopt a risk-stratified approach when determining monitoring frequency
After each side filed their arguments and talked to the judge during several hearings, the judge denied the plaintiffs motion to request this information at this time
Draw up the diluent: Using a clean syringe, draw the calculated volume of bacteriostatic water